EDINBURGH MOLECULAR IMAGING
Edinburgh Molecular Imaging, a Scottish (UK) developer of systemic radiotherapy with cross cancer potential targeting c-Met, was founded in 2014. Originally EMI developed fluorescent optical imaging agents (EMI-137) for detection and surgical guidance of cancer. EMI-137 has passed successfully stage 2b in CRC. In 2019 the company transformed itself into therapeutics, using its c-Mat targeting platform to develop a systemic radiotheragnostic pair [Ga68]EMP-10X / [Lu177/Ac225]EMP-10X. PoC in 16 pa... tiens has been achieved and clinical development has started. The EM Imaging team has decades of documented success in imaging agent discovery and development with expertise spanning medicinal chemistry, biochemistry and cell biology, along with direct clinical expertise. The team has expertise in the clinical development, FDA, EMA approvals, US and EU reimbursement, and broad commercialization in US and EU.
EDINBURGH MOLECULAR IMAGING
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.emimaging.com
Total Employee:
1+
Status:
Active
Contact:
+44 131 658 5306
Email Addresses:
[email protected]
Total Funding:
10.63 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Channel Medsystems
Channel Medystems is a clinical-stage medical technology engaged in the development of proprietary cryo-ablation delivery technologies.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
KBP Biosciences
A multinational clinical stage biotechnology company.
Laboratoires Cyclopharma SA
Laboratoires Cyclopharma SA developing innovative molecular imaging solutions.
Nabsys
Nabsys is a life sciences company focused on the development of solid-state, single-molecule positional sequencing technology.
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
Caribou Property
Caribou Property investment in Venture Round - Edinburgh Molecular Imaging
Pitch@Palace
Pitch@Palace investment in Non Equity Assistance - Edinburgh Molecular Imaging
Scottish Investment Bank
Scottish Investment Bank investment in Series A - Edinburgh Molecular Imaging
Epidarex Capital
Epidarex Capital investment in Series A - Edinburgh Molecular Imaging
Newest Events participated
Participated in Pitch@Palace 5.0
on 2016-03-07 as exhibitor
